Investment
Features
FeesSafety
Academy
More
Pluang+

Alvotech's new FDA-approved process doubles SIMLANDI® output per batch, boosting biosimilar production capacity.

Market News
20 Oct 2026
GlobeNewsWire
View Source
Bullish
Alvotech's new FDA-approved process doubles SIMLANDI® output per batch, boosting biosimilar production capacity.

Alvotech has received FDA approval for a new manufacturing process for SIMLANDI® (adalimumab-ryvk), its biosimilar to Humira®. This updated process more than doubles the drug substance output per batch without increasing the manufacturing scale, enhancing productivity and freeing up capacity in its Reykjavik facility. The improvement supports Alvotech's ability to meet growing demand for its biosimilars while maintaining product quality, safety, and efficacy. This development strengthens Alvotech's manufacturing operations and commercial supply reliability.

Alvotech's new FDA-approved manufacturing process for SIMLANDI® is the subject here, with Pluang's Health sector data providing market context. Of 150 priced Health-sector US stocks on Pluang, 92 rose and 53 fell today. Notable movers include AMWL at USD 12.38 with a 5.99% increase, AHCO at USD 5.79 with 100% buy order activity, and ALMS at USD 6.35, up 3.76%, as of Oct 20, 2026 14:11 WIB.

More News

VINCI wins €165M contract to build cooling plant for Iberian data center campus

VINCI wins €165M contract to build cooling plant for Iberian data center campus

VINCI's subsidiary Cobra IS secured a €165 million contract to construct a cooling plant for a major data center campus in the Iberian Peninsula. The project involves installing mechanical, electrical, and plumbing systems for 126 dry coolers, which ...

Market News
Bullish
2 hours ago
VINCI wins €165M contract for cooling system in large Iberian data center campus

VINCI wins €165M contract for cooling system in large Iberian data center campus

VINCI's subsidiary Cobra IS secured a €165 million contract to build the cooling system for a massive data center campus in the Iberian Peninsula. The project includes installing mechanical, electrical, and plumbing equipment for 126 air cooling unit...

Market News
Bullish
2 hours ago
Basilea presents new data on antifungals fosmanogepix, isavuconazole, and antibiotic ceftobiprole at IDWeek 2026

Basilea presents new data on antifungals fosmanogepix, isavuconazole, and antibiotic ceftobiprole at IDWeek 2026

Basilea Pharmaceutica announced new clinical and activity data for its antifungal drugs fosmanogepix and isavuconazole, as well as the antibiotic ceftobiprole, to be presented at IDWeek 2026 in Washington D.C. Highlights include pediatric data from f...

Market News
Bullish
3 hours ago
Gainsight launches AI-native Atlas managing $75M ARR and new value-based pricing for customer retention.

Gainsight launches AI-native Atlas managing $75M ARR and new value-based pricing for customer retention.

Gainsight introduced its AI-native services business, Atlas, which manages over $75 million in annual recurring revenue (ARR) by handling long-tail customer renewals with AI agents and human managers. The company also announced a shift to value-based...

Market News
Bullish
3 hours ago
Bitget adds 4 new stock-linked perpetual contracts with up to 20x leverage and 24/7 trading.

Bitget adds 4 new stock-linked perpetual contracts with up to 20x leverage and 24/7 trading.

Bitget has expanded its derivatives offerings by adding four new stock-linked perpetual contracts named CSTOCK, MDT, BP, and VLO. These contracts settle in Tether (USDT), support leverage up to 20x, and can be traded 24/7, including weekends. This ex...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App